@article{d1a4284800c44da1a4d2baf7314e8169,
title = "Headache: challenging conventional wisdom",
author = "Dodick, {David W.} and Todd Schwedt",
note = "Funding Information: DWD has been an advisory board consultant for Merck, Allergan, Endo, Pfizer, Coherex, Neuralieve, MAP Pharmaceuticals, and Minster Pharmaceuticals. He has received research support from ANS, Medtronic, and St Jude, and was the principal investigator for the ESCAPE study (Effect of Septal Closure of Atrial PFO on Events of Migraine With Premere). TS has received research support from the National Institutes of Health and National Headache Foundation and has consulted for VerusMed. He has particpated in industry-sponsored research from Allergan, GlaxoSmithKline, and AGA Medical.",
year = "2009",
month = jan,
doi = "10.1016/S1474-4422(08)70275-8",
language = "English (US)",
volume = "8",
pages = "12--14",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "1",
}